Meng-Fen Wu

7.1k citations

18 papers · 2.9k indexed · 1 hit paper · h-index 16

Impact in

Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Immunology top 2%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology

Papers in

Oncology 11
- CAR-T cell therapy research 8
Immunology 7
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 2

Co-authors: Hao LiuGianpietro Dotti Helen E. Heslop Barbara Savoldo Malcolm K. Brenner Cliona M. Rooney Adrian P. Gee Zhuyong Mei
Journals: Blood (3 papers)Molecular Therapy (2 papers)Journal of Clinical Oncology (2 papers)Breast Cancer Research and Treatment (2 papers)Journal of Clinical Investigation (2 papers)
Partner nations: United States Netherlands Switzerland

In The Last Decade

Meng-Fen Wu

18 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma 2011 · 882 citations

Peers

Countries citing papers authored by Meng-Fen Wu

Since Specialization

Citations

This map shows the geographic impact of Meng-Fen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng-Fen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng-Fen Wu more than expected).

Fields of papers citing papers by Meng-Fen Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng-Fen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng-Fen Wu. The network helps show where Meng-Fen Wu may publish in the future.

Co-authors

The 25 scholars most cited alongside Meng-Fen Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Meng-Fen Wu Line = papers co-authored together Meng-Fen Wu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants Cancer Immunology Research ·Giedre Krenciute, Brooke Prinzing, Zhongzhen Yi, Meng-Fen Wu, Hao Liu, Gianpietro Dotti, Irina V. Balyasnikova, Stephen Gottschalk	2017	255
2	Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytes Journal of Clinical Investigation ·Carlos A. Ramos, Brandon Ballard, Huimin Zhang, Olga Dakhova, Adrian P. Gee, Zhuyong Mei, Mrinalini Bilgi, Meng-Fen Wu, Hao Liu, Bambi Grilley, Catherine M. Bollard, Bill H. Chang, Cliona M. Rooney, Malcolm K. Brenner, Helen E. Heslop, Gianpietro Dotti, Barbara Savoldo	2017	279
3	Clinical responses with T lymphocytes targeting malignancy-associated κ light chains Journal of Clinical Investigation ·Carlos A. Ramos, Barbara Savoldo, Vicky Torrano, Brandon Ballard, Huimin Zhang, Olga Dakhova, Enli Liu, George Carrum, Rammurti T. Kamble, Adrian P. Gee, Zhuyong Mei, Meng-Fen Wu, Hao Liu, Bambi Grilley, Cliona M. Rooney, Malcolm K. Brenner, Helen E. Heslop, Gianpietro Dotti	2016	234
4	Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies Biology of Blood and Marrow Transplantation ·Swati Naik, Caridad Martinez, Kathryn Leung, Ghadir Sasa, Ngoc-Yen Nguyen, Meng-Fen Wu, Stephen Gottschalk, Malcolm K. Brenner, Helen E. Heslop, Robert A. Krance	2015	15
5	Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Rα2-positive Glioma Molecular Therapy ·Giedre Krenciute, Simone Krebs, David Torres, Meng-Fen Wu, Hao Liu, Gianpietro Dotti, Xiao‐Nan Li, Maciej S. Lesniak, Irina V. Balyasnikova, Stephen Gottschalk	2015	68
6	Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity Clinical Cancer Research ·Alana A. Kennedy‐Nasser, Stephanie Ku, Paul Castillo‐Caro, Yasmin Hazrat, Meng-Fen Wu, Hao Liu, Jos Melenhorst, A. John Barrett, Sawa Ito, Aaron E. Foster, Barbara Savoldo, Eric Yvon, George Carrum, Carlos A. Ramos, Robert A. Krance, Kathryn Leung, Helen E. Heslop, Malcolm K. Brenner, Catherine M. Bollard	2014	145
7	Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene Blood ·Xiaoou Zhou, Antonio Di Stasi, Siok‐Keen Tey, Robert A. Krance, Caridad Martinez, Kathryn Leung, April Durett, Meng-Fen Wu, Hao Liu, Ann M. Leen, Barbara Savoldo, Yu‐Feng Lin, Bambi Grilley, Adrian P. Gee, David M. Spencer, Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner, Gianpietro Dotti	2014	139
8	T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma Molecular Therapy ·Kevin Chow, Swati Naik, Sunitha Kakarla, Vita S. Brawley, Donald R. Shaffer, Zhongzhen Yi, Nino Rainusso, Meng-Fen Wu, Hao Liu, Yvonne Kew, Robert G. Grossman, Suzanne Z. Powell, Dean A. Lee, Nabil Ahmed, Stephen Gottschalk	2012	196
9	Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model PLoS ONE ·Bhuvanesh Dave, Melissa D. Landis, Lacey E. Dobrolecki, Meng-Fen Wu, Xiaomei Zhang, Thomas F. Westbrook, Susan G. Hilsenbeck, Dan Liu, Michael T. Lewis, David J. Tweardy, Jenny C. Chang	2012	53
10	Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence Breast Cancer Research and Treatment ·C. Smith, Ilenia Migliaccio, Vaishali Chaubal, Meng-Fen Wu, Margaret C. Pace, Ryan J. Hartmaier, Shiming Jiang, Dean P. Edwards, Maya Gutierrez, Susan G. Hilsenbeck, Steffi Oesterreich	2012	12
11	Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladder Urologic Oncology Seminars and Original Investigations ·Seth P. Lerner, Hao Liu, Meng-Fen Wu, Yngvil Kloster Thomas, J. Alfred Witjes	2011	50
12	T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies Blood ·Donald R. Shaffer, Barbara Savoldo, Zhongzhen Yi, Kevin Chow, Sunitha Kakarla, David M. Spencer, Gianpietro Dotti, Meng-Fen Wu, Hao Liu, Shannon C. Kenney, Stephen Gottschalk	2011	131
13	Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma Blood ·Chrystal U. Louis, Barbara Savoldo, Gianpietro Dotti, Martin Pulé, Eric Yvon, Gary D. Myers, Claudia Rössig, Heidi V. Russell, Oumar Diouf, Enli Liu, Hao Liu, Meng-Fen Wu, Adrian P. Gee, Zhuyong Mei, Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner Hit paper breakdown →	2011	882
14	Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma Journal of Immunotherapy ·Chrystal U. Louis, Karin Straathof, Catherine M. Bollard, Sravya Ennamuri, Claudia Gerken, Teresita Lopez, M. Helen Huls, Andrea M. Sheehan, Meng-Fen Wu, Hao Liu, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop, Stephen Gottschalk	2010	160
15	Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancers Journal of Clinical Oncology ·Bhuvanesh Dave, Ilenia Migliaccio, Maya Gutierrez, Meng-Fen Wu, Gary C. Chamness, Helen Wong, Archana Narasanna, Anindita Chakrabarty, Susan G. Hilsenbeck, Jian Huang, Mothaffar F. Rimawi, Rachel Schiff, Carlos L. Arteaga, C. Kent Osborne, Jenny C. Chang	2010	190
16	The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer Breast Cancer Research and Treatment ·Meng-Fen Wu, Susan G. Hilsenbeck, Yee Lu Tham, Rita Kramer, Richard Elledge, J. C. Chang, Lois C. Friedman	2009	17
17	Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model Urologic Oncology Seminars and Original Investigations ·Guru Sonpavde, Weiguo Jian, Hao Liu, Meng-Fen Wu, Steven S. Shen, Seth P. Lerner	2008	65
18	Phase I Pharmacokinetic and Pharmacodynamic Study of Temozolomide in Pediatric Patients With Refractory or Recurrent Leukemia: A Children's Oncology Group Study Journal of Clinical Oncology ·Terzah M. Horton, Patrick A. Thompson, Stacey L. Berg, Peter C. Adamson, Ashish M. Ingle, M. Eileen Dolan, Shannon M. Delaney, Madhuri Hedge, Heidi L. Weiss, Meng-Fen Wu, Susan M. Blaney	2007	16

About Meng-Fen Wu

Meng-Fen Wu is a scholar working on Oncology, Immunology, Hematology, Genetics and Genetics, having authored 18 papers that have together received 2.9k indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (6 papers), Hematopoietic Stem Cell Transplantation (3 papers), Virus-based gene therapy research (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Immunotherapy and Immune Responses (2 papers), Estrogen and related hormone effects (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Oncology (2.4k citations), Immunology (1.0k citations), Genetics (743 citations), Genetics (194 citations) and Hematology (191 citations). Meng-Fen Wu has collaborated with scholars based in United States, Netherlands and Switzerland. Frequent co-authors include Hao Liu, Gianpietro Dotti, Helen E. Heslop, Barbara Savoldo, Malcolm K. Brenner, Cliona M. Rooney, Adrian P. Gee, Zhuyong Mei, Stephen Gottschalk and Enli Liu. Their work appears in journals such as Blood, Molecular Therapy, Journal of Clinical Oncology, Breast Cancer Research and Treatment and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact